State of the Art in Adults With ALL: Salvage & 1L Ino and Blina + Chemo, Ponatinib-Blina in Ph+ Disease, Bcl2-Bclxl Inhibitors, CAR-T in Early Salvage and 1L

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Palliative & Supportive Care
Basic Science
COVID-19
Leukemia
Lymphoma
Myeloma
MDS and MPN
Benign Hematology
Lung
Business
Event

Playback speed

10 seconds

State of the Art in Adults With ALL: Salvage & 1L Ino and Blina + Chemo, Ponatinib-Blina in Ph+ Disease, Bcl2-Bclxl Inhibitors, CAR-T in Early Salvage and 1L

By XIth Eurasian Hematology-Oncology Congress - EHOC 2020 FEATURING Elias Jabbour

23 views

January 18, 2021

Comments 0

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley

Leukemia

Pre-Pandemic CML Treatment: What Is CGA? How Do Ponatinib, Nilotinib…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

P. Raanani

15 views

Challenges in Treatment of Leukemias and Bone Marrow Failure in Deve…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

K. Rashid

15 views

AML Treatment in Developing Countries: LIMC vs. HIC Differences - St…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

E. Rego

13 views

Cytogenetic Characterization in AML: How Do Gene Mutations Impact Ov…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

M. Yilmaz

132 views

Targeted Therapy for Older Patients With AML: Is Addition of GO to I…

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

C. Schiffer

38 views